Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

Raymond H. Chan(Beth Israel Deaconess Medical Center), Martin S. Maron(Beth Israel Deaconess Medical Center), Andrew Crean(Stollery Children's Hospital), C. Michael Gibson(Baim Institute for Clinical Research), Claudio Rapezzi(University of Ferrara), Ethan J. Rowin(Beth Israel Deaconess Medical Center), Camillo Autore(Sapienza University of Rome), Gabriele Egidy Assenza(Boston Children's Hospital), Iacopo Olivotto(Azienda Ospedaliero-Universitaria Careggi), Tammy S. Haas(Beth Israel Deaconess Medical Center), Benedetta Tomberli(Beth Israel Deaconess Medical Center), Barry J. Maron(Lahey Hospital and Medical Center), Paolo Spirito(University of Naples Federico II), John R. Lesser(Minneapolis Heart Institute Foundation), Massimo Lombardi(Fondazione Toscana Gabriele Monasterio), Evan Appelbaum(Harvard University Press), Michael Pencina(Morehouse School of Medicine), Elena Biagini, James E. Udelson(Tufts Medical Center), Carlo N. De Cecco(Emory Healthcare), Franco Cecchi(Azienda Ospedaliero-Universitaria Careggi), Christiane Gruner(Zurich Heart House), Harry Rakowski(University Health Network), E. Francis Cook(Brigham and Women's Hospital), Warren J. Manning(Beth Israel Deaconess Medical Center), Francesco Formisano(Worcestershire Acute Hospitals NHS Trust), Susie N. Hong(University of Maryland, Baltimore)
Circulation
August 4, 2014
Cited by 1,045


Related Papers